36C10G24R0013 0004_1.docx

This document is a combined synopsis and solicitation from the Department of Veterans Affairs seeking tumor molecular testing services. The solicitation seeks proposals for comprehensive reference laboratory-based tumor molecular profiling services including next generation sequencing panels for solid and hematological malignancies as well as complementary tests such as immunohistochemistry and fluorescence in situ hybridization to guide clinical care for Veterans with cancer. Interested offerors must submit proposals by January 31, 2024 at 13:00 Eastern Time in response to solicitation number 36C10G24R0013. Award will be made based on best value determined by evaluating technical approach, past performance, socio-economic considerations and price, with non-price factors significantly more important than price. Services will be provided virtually from the contractor's location throughout the United States.

The solicitation seeks proposals for four line items including solid tumor, liquid tumor, and hematological malignancy next generation sequencing tests as well as an immunohistochemistry test. The Strategic Acquisition Center is procuring these specialized molecular testing services to support the Veterans Health Administration National Precision Oncology Program's clinical care of Veterans with cancer.